Australia Plans to Raise Legal THC Percentage for Hemp Farmers | CashCropToday
0 Shares 245 Views

Australia Plans to Raise Legal THC Percentage for Hemp Farmers

February 26, 2018
245 Views

Australia plans to raise the legal percentage of the legal amount of THC found in commercial industrial hemp cultivation for farmer’s throughout the continent. The Australian Prime Minister believes this change in legislation will allow new cultivars of hemp to be grown that have been considered illegal for decades.

Australia has recently legalized the cultivation of industrial hemp for food consumption purposes. The new legal limit of THC within the hemp industry in Australia has been raised by an entire percent. Industrial hemp farmers will now be able to cultivate varieties that produce up to 1.35% THC. These less stringent guidelines allows for farmers to diversify the types of hemp they grow.

Australia has issued 42 commercial industrial hemp licenses to farmers, mostly in the western part of the country. Prime Minister MacTiernan believes the revival of the hemp industry will create a new profitable export, as well as create agricultural jobs for Australians.

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
270 views
Market Watch
270 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
194 views
Global
194 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
190 views
Manufacturing
190 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: